Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Gruenberger, Birgit ^a   Scheithauer, Werner ^a   Punzengruber, Robert ^a   Zielinski, Christoph ^a   Tamandl, Dietmar ^a   Gruenberger, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FOLFOX PROTOCOL; PLATINUM COMPLEX; UNCLASSIFIED DRUG; XELOX;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HAND FOOT SYNDROME; HUMAN; LIVER METASTASIS; LIVER RESECTION; LONG TERM CARE; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RECURRENCE RISK; RISK REDUCTION; THROMBOCYTOPENIA; TREATMENT DURATION; ADJUVANT THERAPY; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 44149107591     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-120     Document Type: Article

References (33)

1. Landis SH Murray T Bolden S Wingo PA Cancer statistics, 1999 CA Cancer J Clin 1999, 49(1):8-31. 10.3322/canjclin.49.1.8 10200775
2. Midgley R Kerr D Colorectal cancer Lancet 1999, 353:391-399. 10.1016/ S0140-6736(98)07127-X 9950460
3. Williams NS Northover JMA Arnott SJ Colorectal tumors Oxford Textbook of Oncology Oxford, Oxford University Press Peckham M, Pinedo H, Veronesi U 1995, 1133-1168.
4. Scheithauer W Rosen H Kornek GV Sebesta C Depisch D Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer BMJ 1993, 306(6880):752-755. 1677246 7683942
5. Scheithauer W Kornek GV Raderer M Schull B Schmid K Kovats E Schneeweiss B Lang F Lenauer A Depisch D Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer J Clin Oncol 2003, 21(7):1307-1312. 10.1200/JCO.2003.09.016 12663719
6. Douillard JY Cunningham D Roth AD Navarro M James RD Karasek P Jandik P Iveson T Carmichael J Alakl M Gruia G Awad L Rougier P Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial The Lancet 2000, 355(9209):1041-1047. 10.1016/ S0140-6736(00)02034-1
7. Giacchetti S Perpoint B Zidani R Le Bail N Faggiuolo R Focan C Chollet P Llory JF Letourneau Y Coudert B Bertheaut-Cvitkovic F Larregain-Fournier D Le Rol A Walter S Adam R Misset JL Levi F Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil-Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer J Clin Oncol 2000, 18(1):136-147. 10623704
8. Fong Y Fortner J Sun R Brennan M Blumgart L Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer: Analysis of 1001 Consecutive Cases Ann Surg 1999, 230(3):309-321. 1420876 10493478 10.1097/00000658-199909000-00004
9. Choti MA Sitzmann JV Tiburi MF Sumetchotimetha W Rangsin R Schulick RD Lillemoe KD Yeo CJ Cameron JL Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 2002, 235(6):759-766. 1422504 12035031 10.1097/00000658-200206000-00002
10. Zakaria S Donohue JH Que FG Farnell MB Schleck CD Ilstrup DM Nagorney DM Hepatic resection of colorectal metastases; value for risk scoringsystems? Annals of Surgery 2007, 246:183-191. 1933577 17667495 10.1097/SLA.0b013e3180603039
11. Panis Y Ribeiro J Chrétien Y Nordlinger B Dormant liver metastases: An experimental study Br J Surg 1992, 79(3):221-223. 10.1002/ bjs.1800790309 1555087
12. Lorenz M Mueller H Schramm H Gassel H Rau H Ridwelski K Hauss J Stieger R Jauch K Bechstein W Encke A Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-Fluorouracil and Folonic Acid for liver metastases of colorectal cancer Ann Surg 1998, 228(6):756-762. 1191593 9860474 10.1097/00000658-199812000-00006
13. Kemeny MM Adak S Gray B Macdonald JS Smith T Lipsitz S Sigurdson ER O'Dwyer PJ Benson AB III Combined-Modality Treatment for Resectable Metastatic Colorectal Carcinoma to the Liver: Surgical Resection of Hepatic Metastases in Combination With Continuous Infusion of Chemotherapy--An Intergroup Study J Clin Oncol 2002, 20(6);1499-1505. 10.1200/JCO.20.6.1499 11896097
14. Kemeny N Huang Y Cohen AM Shi W Conti JA Brennan MF Bertino JR Turnbull AD Sullivan D Stockman J Blumgart LH Fong Y Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 1999, 341(27):2039-2048. 10.1056/NEJM199912303412702 10615075
15. Taieb J Artru P Paye F Louvet C Perez N Andre T Gayet B Hebbar M Goebel FM Tournigand C Parc R de Gramont A Intensive Systemic Chemotherapy Combined With Surgery for Metastatic Colorectal Cancer: Results of a Phase II Study J Clin Oncol 2005, 23(3):502-509. 10.1200/JCO.2005.05.082 15659495
16. Wein A Riedel C Brückl W Merkel S Ott R Hanke B Baum U Fuchs F Günther K Reck T Papadopoulos T Hahn EG Hohenberger W Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer Oncology 2003, 64(2):131-138. 10.1159/ 000067772 12566910
17. Gruenberger T Gruenberger B Becherer A Kettenbach J Dieckmann K Schima W Interdisciplinary management of colorectal cancer liver metastases European Surgery 2006, 38(2):107-111. 10.1007/s10353-006-0229-9
18. MacDonald J Haller D Mayer R Grading of Toxicity Manual of Oncologic Therapeutics Philadelphia, Lippincott MacDonald J, Haller D, Mayer R 1995, 519-523.
19. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J Van Glabbeke M van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000, 92(3):205-216. 10.1093/jnci/92.3.205 10655437
20. Kemeny NE Kemeny MM Lawrence TS Liver metastases Clinical Oncology New York, Churchill Livingstone Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE 2000, 886-921.
21. Tanaka K Adam R Shimada H Azoulay D Levi F Bismuth H Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 2003, 90:963-969. 10.1002/bjs.4160 12905549
22. Allen PJ Kemeny N Jarnagin W DeMatteo R Blumgart L Fong Y Importance of Response to Neoadjuvant Chemotherapy in Patients Undergoing Resection of Synchronous Colorectal Liver Metastases Journal of Gastrointestinal Surgery 2003, 7(1):109-117. 10.1016/S1091-255X(02)00121-X 12559192
23. Nordlinger B Sorbye H Collette L Glimelius B Poston GJ Schlag PM Rougier P Bechstein W Walpole ET Gruenberger T Final results of the EORTC Intergroup randomized phase III study 40983 (EPOC) evaluating the benefits of peri-operative Folfox 4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases J Clin Oncol (Meeting Abstracts) 2007, 25(20 Suppl):2S. Abstract LBA5
24. Adam R Pascal G Castaing D Azoulay D Delvart V Paule B Levi F Bismuth H Tumor progression while on chemotherapy; a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004, 240(6):1052-1064. 1356520 15570210 10.1097/01.sla.0000145964.08365.01
25. Grothey A Alberts SR Rational for adjuvant and neoadjuvant chemotherapy in the resection of liver metastases Colorectal Cancer; evidence-based chemotherapy strategies New Jersey, Humana Press Saltz LB 2007, 191-203.
26. Kabbinavar FF Schulz J McCleod M Patel T Hamm JT Hecht JR Mass R Perrou B Nelson B Novotny WF Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial J Clin Oncol 2005, 23(16):3697-3705. 10.1200/ JCO.2005.05.112 15738537
27. Hurwitz H Fehrenbacher L Novotny W Cartwright T Hainsworth J Heim W Berlin J Baron A Griffing S Holmgren E Ferrara N Fyfe G Rogers B Ross R Kabbinavar F Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer N Engl J Med 2004, 350(23):2335-2342. 10.1056/NEJMoa032691 15175435
28. Giantonio BJ Catalano PJ Meropol NJ O'Dwyer PJ Mitchell EP Alberts SR Schwartz MA Benson AB III Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 J Clin Oncol 2007, 25(12):1539-1544. 10.1200/ JCO.2006.09.6305 17442997
29. Cunningham D Humblet Y Siena S Khayat D Bleiberg H Santoro A Bets D Mueser M Harstrick A Verslype C Chau I Van Cutsem E Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer N Engl J Med 2004, 351(4):337-345. 10.1056/ NEJMoa033025 15269313
30. Díaz Rubio E Tabernero J van Cutsem E Cervantes A André T Humblet Y Soulié P Corretgé S Kisker S de Gramont A Cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer: An international phase II study J Clin Oncol (Meeting Abstracts) 2005, 23(16 Suppl):254.
31. Van Cutsem E Nowacki M Lang I Cascinu S Shchepotin I Maurel J Rougier P Cunningham D Nippgen J Köhne C Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial J Clin Oncol (Meeting Abstracts) 2007, 25 June 20(suppl):164s. (Abstract 4000)
32. Gruenberger T Gruenberger B Scheithauer W Neoadjuvant Therapy With Bevacizumab J Clin Oncol 2006, 24(16):2592-2593. 10.1200/ JCO.2005.05.2910 16735714
33. Tamandl D Gruenberger B Herberger B Schoppmann S Bodingbauer M Schindl M Puhalla H Fleischmann E Schima W Jakesz R Laengle F Gruenberger T Selective resection of colorectal liver metastases European Journal of Surgical Oncology 2007, 33(2):174-182. 10.1016/j.ejso.2006.09.008 17046194